Theravance Biopharma Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome everyone to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team.
Our next presenting company is Theravance. Speaking on behalf of the company, we have CEO, Rick Winningham.
Rick, before I turn it over to you, I just wanted to remind everybody that if you have a question, please use the Ask a Question feature in the portal. And I'm happy to ask the question on your behalf.
With that, I'll turn it over to you, Rick. Rick?
Good morning from the Bay Area. Thank you, Anupam, for inviting us to present and also I'd like to thank JPMorgan. If you've not been paying attention to Theravance Biopharma prior to this, 2021 is the year to pay attention.
On the next slide, I've just got the forward-looking statements. I will be making some forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
